Nkarta, Inc. (Nasdaq:NKTX)
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.
1150 Veterans Boulevard
South San Francisco, California 94080
150
$1.6400
1.5700 - 1.6700
1.5700 - 16.2400
1.46M
9.62M (02/14/25)
20.79%
$115.73M
N/A
-$117.5M
N/A
Director George Vratsanos |
Chairman Ali Behbahani |
Independent Director Zach Scheiner |
Independent Director Angela M. Thedinga |
Independent Director Michael Dybbs |
Independent Director Simeon J. George |
Independent Director Leone D. Patterson |
Date | Form | Event |
---|---|---|
13 Dec, 2024 | SC 13G | |
14 Nov, 2024 | SC 13G/A | |
14 Nov, 2024 | SC 13G/A | |
12 Nov, 2024 | SC 13G/A | |
8 Nov, 2024 | SC 13G | |
7 Nov, 2024 | 10-Q | |
7 Nov, 2024 | 8-K | |
25 Oct, 2024 | SC 13G/A | |
24 Oct, 2024 | SC 13G | |
23 Aug, 2024 | 4 | |
16 Aug, 2024 | 8-K/A | |
13 Aug, 2024 | 10-Q | |
13 Aug, 2024 | 8-K | |
31 Jul, 2024 | 4 | |
31 Jul, 2024 | 3 | |
31 Jul, 2024 | 4 | |
18 Jul, 2024 | 4 | |
16 Jul, 2024 | 8-K | |
16 Jul, 2024 | 144 | |
27 Jun, 2024 | 8-K | |
20 Jun, 2024 | 4 | |
20 Jun, 2024 | 4 | |
20 Jun, 2024 | 4 | |
20 Jun, 2024 | 4 | |
20 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 3 | |
13 Jun, 2024 | 8-K | |
9 May, 2024 | 10-Q | |
9 May, 2024 | 8-K | |
25 Apr, 2024 | DEFA14A | |
25 Apr, 2024 | DEF 14A | |
25 Apr, 2024 | ARS | |
15 Apr, 2024 | PRE 14A | |
5 Apr, 2024 | SC 13G/A | |
29 Mar, 2024 | SC 13D/A | |
29 Mar, 2024 | SC 13D/A | |
29 Mar, 2024 | 4 | |
28 Mar, 2024 | 8-K | |
28 Mar, 2024 | 4 | |
28 Mar, 2024 | SC 13D/A | |
28 Mar, 2024 | SC 13D/A | |
26 Mar, 2024 | 424B5 | |
25 Mar, 2024 | 8-K | |
21 Mar, 2024 | 10-K | |
21 Mar, 2024 | 8-K | |
5 Mar, 2024 | 4 | |
5 Mar, 2024 | 4 | |
4 Mar, 2024 | 144 | |
1 Mar, 2024 | 144 | |
1 Mar, 2024 | 144 | |
14 Feb, 2024 | 4 | |
12 Feb, 2024 | 144 | |
9 Feb, 2024 | SC 13D/A | |
7 Feb, 2024 | SC 13G/A | |
31 Jan, 2024 | SC 13G/A | |
18 Jan, 2024 | 4 | |
18 Jan, 2024 | 4 | |
18 Jan, 2024 | 4 | |
18 Jan, 2024 | 4 | |
18 Jan, 2024 | 4 | |
18 Jan, 2024 | SC 13G | |
8 Jan, 2024 | 8-K | |
8 Jan, 2024 | 4 | |
8 Jan, 2024 | 4 | |
8 Jan, 2024 | 4 | |
8 Jan, 2024 | 4 | |
8 Jan, 2024 | 4 | |
8 Jan, 2024 | 4 | |
3 Jan, 2024 | S-8 | |
13 Nov, 2023 | SC 13G/A | |
9 Nov, 2023 | 8-K | |
9 Nov, 2023 | 10-Q | |
3 Nov, 2023 | SC 13G | |
27 Oct, 2023 | SC 13G | |
26 Oct, 2023 | SC 13G | |
17 Oct, 2023 | 8-K | |
16 Oct, 2023 | 8-K | |
10 Oct, 2023 | SC 13G/A | |
23 Aug, 2023 | 4 | |
10 Aug, 2023 | 8-K | |
10 Aug, 2023 | 10-Q | |
5 Jul, 2023 | 4 | |
5 Jul, 2023 | 4 | |
5 Jul, 2023 | 8-K | |
5 Jul, 2023 | 3 | |
27 Jun, 2023 | 8-K | |
26 Jun, 2023 | 8-K | |
22 Jun, 2023 | 4 | |
22 Jun, 2023 | 4 | |
22 Jun, 2023 | 4 | |
22 Jun, 2023 | 4 | |
22 Jun, 2023 | 4 | |
22 Jun, 2023 | 4 | |
9 Jun, 2023 | 4 | |
9 Jun, 2023 | 4 | |
9 Jun, 2023 | 4 | |
9 Jun, 2023 | 4 | |
9 Jun, 2023 | 4 | |
9 Jun, 2023 | 8-K | |
9 Jun, 2023 | 4 | |
9 Jun, 2023 | 4 | |
9 Jun, 2023 | 4 | |
11 May, 2023 | 10-Q | |
11 May, 2023 | 8-K | |
10 May, 2023 | SC 13G/A | |
5 May, 2023 | EFFECT | |
3 May, 2023 | CORRESP | |
24 Apr, 2023 | ARS | |
24 Apr, 2023 | S-3/A | |
24 Apr, 2023 | DEFA14A | |
24 Apr, 2023 | DEF 14A | |
14 Apr, 2023 | PRE 14A | |
30 Mar, 2023 | 8-K | CEO Change |
21 Mar, 2023 | UPLOAD | |
17 Mar, 2023 | S-3 | |
16 Mar, 2023 | 10-K | |
16 Mar, 2023 | 8-K | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13D/A | |
10 Feb, 2023 | SC 13G | |
10 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G | |
3 Feb, 2023 | SC 13G | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
10 Jan, 2023 | 3 | |
9 Jan, 2023 | 8-K | |
9 Jan, 2023 | S-8 | |
5 Dec, 2022 | 8-K | |
2 Dec, 2022 | 8-K | |
9 Nov, 2022 | 10-Q | |
9 Nov, 2022 | 8-K | |
7 Oct, 2022 | 4 | |
30 Sep, 2022 | 4 | |
22 Sep, 2022 | 4 | |
17 Aug, 2022 | 4 | |
17 Aug, 2022 | 4 | |
17 Aug, 2022 | 4 | |
11 Aug, 2022 | 8-K | |
11 Aug, 2022 | 10-Q | |
10 Aug, 2022 | 4 | |
10 Aug, 2022 | 4 | |
26 Jul, 2022 | 4 | |
26 Jul, 2022 | 4 | |
18 Jul, 2022 | 4 | |
21 Jun, 2022 | 4 | |
21 Jun, 2022 | 4 | |
21 Jun, 2022 | 4 | |
21 Jun, 2022 | 4 | |
21 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 8-K | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
7 Jun, 2022 | 4 | |
3 Jun, 2022 | SC 13D/A | |
16 May, 2022 | 8-K | |
13 May, 2022 | SC 13D/A | |
12 May, 2022 | 8-K | |
12 May, 2022 | 10-Q | |
5 May, 2022 | SC 13D/A | |
2 May, 2022 | SC 13D/A | |
2 May, 2022 | SC 13D/A | |
29 Apr, 2022 | 4 | |
28 Apr, 2022 | 4 | |
28 Apr, 2022 | 8-K | |
26 Apr, 2022 | 424B5 | |
25 Apr, 2022 | 8-K | |
25 Apr, 2022 | 424B5 | |
22 Apr, 2022 | 8-K | |
21 Apr, 2022 | DEF 14A | |
21 Apr, 2022 | DEFA14A | |
29 Mar, 2022 | 8-K | |
29 Mar, 2022 | 3 | |
29 Mar, 2022 | 4 | |
17 Mar, 2022 | 10-K | |
17 Mar, 2022 | S-8 | |
17 Mar, 2022 | 8-K | |
18 Feb, 2022 | SC 13G | |
14 Feb, 2022 | SC 13G/A | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
3 Dec, 2021 | 4 | |
22 Nov, 2021 | SC 13D/A | |
10 Nov, 2021 | 10-Q | |
10 Nov, 2021 | 8-K | |
22 Oct, 2021 | 8-K | |
7 Oct, 2021 | 8-K | |
1 Oct, 2021 | 4 | |
3 Sep, 2021 | 424B5 | |
2 Sep, 2021 | 4 | |
2 Sep, 2021 | EFFECT | |
31 Aug, 2021 | CORRESP | |
18 Aug, 2021 | UPLOAD | |
12 Aug, 2021 | 10-Q | |
12 Aug, 2021 | 8-K | |
12 Aug, 2021 | S-3 | |
9 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
14 Jul, 2021 | 8-K | |
12 Jul, 2021 | SC 13G/A | |
6 Jul, 2021 | 4 | |
23 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 8-K | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
4 Jun, 2021 | 4 | |
13 May, 2021 | 8-K | |
13 May, 2021 | 10-Q | |
12 May, 2021 | 4 | |
6 May, 2021 | 8-K | |
5 May, 2021 | 4 | |
28 Apr, 2021 | 8-K | |
22 Apr, 2021 | DEFA14A | |
22 Apr, 2021 | DEF 14A | |
5 Apr, 2021 | 4 | |
2 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
31 Mar, 2021 | 3 | |
25 Mar, 2021 | 10-K | |
25 Mar, 2021 | 8-K | |
16 Feb, 2021 | SC 13G/A | |
12 Feb, 2021 | SC 13G/A | |
3 Feb, 2021 | 4 | |
2 Feb, 2021 | SC 13G | |
26 Jan, 2021 | 4 | |
19 Jan, 2021 | 4 | |
19 Jan, 2021 | 8-K | |
15 Jan, 2021 | S-8 | |
13 Jan, 2021 | 8-K | |
12 Jan, 2021 | 4 | |
12 Jan, 2021 | 4 | |
12 Jan, 2021 | 4 | |
12 Jan, 2021 | 4 | |
12 Jan, 2021 | 4 |
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.